Journal article
The association of basal insulin treatment versus standard care with outcomes in anti‐GAD positive and negative subjects: A post‐hoc analysis of the ORIGIN trial
Abstract
We compared cardiovascular and other outcomes in patients with dysglycaemia with or without anti-glutamic acid dehydrogenase (GAD) antibodies participating in the Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial. Of the 12 537 participants, 8162 had anti-GAD measured at baseline and 267 were anti-GAD positive. The effects of insulin glargine versus standard care and of n-3 fatty acids supplements versus placebo were compared …
Authors
Birkeland KI; Grill V; Wium C; McQueen MJ; Lopez‐Jaramillo P; Lee SF; Gerstein HC
Journal
Diabetes Obesity and Metabolism, Vol. 21, No. 2, pp. 429–433
Publisher
Wiley
Publication Date
February 2019
DOI
10.1111/dom.13528
ISSN
1462-8902